Credit Suisse’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.47M | Sell |
120,757
-17,087
| -12% | -$491K | ﹤0.01% | 1506 |
|
|
2023
Q4 | $4.52M | Buy |
137,844
+64,286
| +87% | +$2.11M | ﹤0.01% | 1390 |
|
|
2023
Q3 | $2.05M | Buy |
73,558
+28,580
| +64% | +$796K | ﹤0.01% | 1816 |
|
|
2023
Q2 | $1.53M | Sell |
44,978
-15,325
| -25% | -$522K | ﹤0.01% | 2090 |
|
|
2023
Q1 | $1.81M | Buy |
60,303
+18,017
| +43% | +$542K | ﹤0.01% | 1928 |
|
|
2022
Q4 | $1.19M | Sell |
42,286
-20,578
| -33% | -$581K | ﹤0.01% | 2211 |
|
|
2022
Q3 | $2.07M | Sell |
62,864
-35,346
| -36% | -$1.16M | ﹤0.01% | 1815 |
|
|
2022
Q2 | $3.09M | Sell |
98,210
-89,226
| -48% | -$2.81M | ﹤0.01% | 1602 |
|
|
2022
Q1 | $8.61M | Sell |
187,436
-96,585
| -34% | -$4.44M | 0.01% | 1106 |
|
|
2021
Q4 | $17.4M | Buy |
284,021
+172,380
| +154% | +$10.6M | 0.01% | 850 |
|
|
2021
Q3 | $8.34M | Buy |
111,641
+32,301
| +41% | +$2.41M | ﹤0.01% | 1230 |
|
|
2021
Q2 | $7.34M | Sell |
79,340
-17,420
| -18% | -$1.61M | ﹤0.01% | 1305 |
|
|
2021
Q1 | $8.59M | Buy |
96,760
+83,760
| +644% | +$7.43M | ﹤0.01% | 1242 |
|
|
2020
Q4 | $1.21M | Buy |
13,000
+2,500
| +24% | +$233K | ﹤0.01% | 2447 |
|
|
2020
Q3 | $669K | Hold |
10,500
| – | – | ﹤0.01% | 2513 |
|
|
2020
Q2 | $548K | Buy |
+10,500
| New | +$548K | ﹤0.01% | 2646 |
|